Belly Fat Is a Better Risk Calculator for Blood Cancers Than BMI
BMI often relies on self-reported weight and height values, and therefore may be a less accurate predictor of cancer risk than alternative body composition measurements.
BMI
Outcomes in Bladder Cancer Tend to Be Poorer With Higher Body Mass Index
An increased body mass index (BMI) may negatively affect disease progression in patients with T1G3 non-muscle-invasive bladder cancer, according to study data.
High BMI Among Premenopausal Women May Improve Risk for Breast Cancer
Researchers report on a study to determine the relationship between BMI and risk for breast cancer among younger women, particularly those 18 to 24 years old.
Obesity, Male Gender May Improve Survival Outcomes with Targeted and Immunotherapy in Melanoma
A retrospective study evaluated the relationship of BMI with survival outcomes among patients with metastatic melanoma who received targeted therapy, immunotherapy, or chemotherapy.
Colorectal Cancer Recurrence Lower in Survivors Who Exercise
Researchers examined the impact of exercise and low body fat mass on recurrence of colorectal polyps among survivors of colorectal cancer.
Arm Measurements a Better Assessment of Nutritional Status in Childhood Cancer Survivors
Arm anthropometry is a better tool for assessing nutritional status of survivors of childhood cancer.
Fewer Americans Trying to Lose Weight
More individuals in the United States are overweight and obese than two decades ago, but fewer are trying to shed pounds.
Earlier and Later Adult BMI Associated With Multiple Myeloma Risk
Younger and usual adult body mass index (BMI) may be linked to increased risk for developing multiple myeloma, research indicates.
Increasing Weight Associated With Disease Progression in Multiple Myeloma
Increasing body mass index (BMI) allows growth and progression of disease in patients with multiple myeloma, a recently published study has shown.
Direct Measures of Body Composition, not BMI, Needed to Track Obesity During Leukemia Treatment
Change in BMI does not reflect body composition of patients undergoing treatment for ALL, suggesting direct measures of body composition should be used to evaluate obesity in patients with leukemia.
